Cited by — Osimertinib plus Gefitinib in Patients with EGFR -Mutated Advanced Non–Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Osimertinib plus Gefitinib in Patients with EGFR -Mutated Advanced Non–Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD.
No admitted local citation edges point to this work yet.
